Anticorps Monoclonal anti-S100B

S100B Monoclonal Antibody for WB, IHC, IF-P, Indirect ELISA

Hôte / Isotype

Mouse / IgG1

Réactivité testée

Humain, rat

Applications

WB, IHC, IF-P, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

1G10F4

N° de cat : 66616-1-PBS

Synonymes

S100 beta, 1G10F4, Protein S100 B, Protein S100-B, S100 calcium-binding protein B



Informations sur le produit

66616-1-PBS cible S100B dans les applications de WB, IHC, IF-P, Indirect ELISA et montre une réactivité avec des échantillons Humain, rat

Réactivité Humain, rat
Hôte / Isotype Mouse / IgG1
Clonalité Monoclonal
Type Anticorps
Immunogène S100B Protéine recombinante Ag7440
Nom complet S100 calcium binding protein B
Masse moléculaire calculée 11 kDa
Poids moléculaire observé 11 kDa
Numéro d’acquisition GenBankBC001766
Symbole du gène S100 Beta
Identification du gène (NCBI) 6285
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine G
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

S100B is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs and has been implicated in the regulation of cellular activities such as metabolism, motility and proliferation. In the nervous system, S100B is constitutively released by astrocytes into the extracellular space and at nanomolar concentrations, it can promote neurite outgrowth and protect neurons against oxidative stress. Within the central nervous system (CNS), S100B is thought to be a marker for astroglial activation, linking astrocyte dysfunction to schizophrenia. In addition to astrocytes, S100B is released from many cell types, such as, adipocytes, chondrocytes, cardiomyocytes and lymphocytes. Serum S100B represents a new biomarker for mood disorders.

{{ptg:RelatedPrimaryAntibodies}}